.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Queensland Health
Healthtrust
Daiichi Sankyo
Cantor Fitzgerald
Cipla
Colorcon
Citi
Dow

Generated: January 21, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: zanamivir

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
GlaxosmithklineRELENZAzanamivirPOWDER;INHALATION021036NDAGlaxoSmithKline LLC0173-0681-015 PACKAGE in 1 CARTON (0173-0681-01) > 4 POWDER in 1 PACKAGE
GlaxosmithklineRELENZAzanamivirPOWDER;INHALATION021036NDAPhysicians Total Care, Inc.54868-4377-05 PACKAGE in 1 CARTON (54868-4377-0) > 4 POWDER in 1 PACKAGE
GlaxosmithklineRELENZAzanamivirPOWDER;INHALATION021036NDADispensing Solutions Inc.68258-3030-15 PACKAGE in 1 CARTON (68258-3030-1) > 4 POWDER in 1 PACKAGE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Dow
Healthtrust
Julphar
Cantor Fitzgerald
Harvard Business School
Citi
Deloitte
Daiichi Sankyo
Boehringer Ingelheim

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot